MedPath

Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods

Not Applicable
Completed
Conditions
Pancreatic Duct Stricture
Bile Duct Stricture
Accuracy of Tissue Diagnosis
Interventions
Procedure: ERCP with cholangiopancreatoscopy
Registration Number
NCT01227382
Lead Sponsor
University of Florida
Brief Summary

The investigators are evaluating the use of a SpyBite biopsy forceps for tissue diagnosis when compared to standard biopsy techniques.

Detailed Description

The participants will undergo an Endoscopic Retrograde Cholangiopancreatography (ERCP) with cholangiopancreatoscopy and evaluation of a bile duct or pancreatic duct stricture with three different types of techniques for biopsy: SpyBite biopsy forceps, cytology brush and RJ3biopsy forceps.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  1. Subjects is 18 years or older
  2. Scheduled to undergo Endoscopic Retrograde Cholangiopancreatography (ERCP) wiht cholangioscopy and/or pancreatoscopy at the University of Florida Gainesville Florida as medically indicated.
  3. Lesion of the pancreatobiliary system that requires tissue sampling as medically indicated
  4. Subject myst be able to give informed consent
Exclusion Criteria
  1. Any contraindication to Endoscopic Retrograde Cholangiopancreatography (ERCP)
  2. The subject is unable to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ERCP with CholangiopancreatoscopyERCP with cholangiopancreatoscopyThe subjects who have been scheduled for an Endoscopic Retrograde Cholangiopancreatography (ERCP) with Cholangiopancreatoscopy for evaluation of a bile duct or pancreatic duct stricture sampling.
Primary Outcome Measures
NameTimeMethod
Percentage of Participants With Accurate Diagnoses of Cancerup to 7 days after the procedure

The diagnostic accuracy of the Spybite Biopsy forceps was compared to both the cytology brush and the RJ3 biopsy forceps sampling of any stricture or biliary lesions found on Endoscopic Retrograde Cholangiopancreatography (ERCP). All three methods were used at baseline to obtain a sample for the determination of cancer vs. no cancer.

Secondary Outcome Measures
NameTimeMethod
Procedure Technical Successday 1

The procedure technical success was defined when all of the following criteria were met: Successful advancement of the cholangioscope to the desired target, adequate cholangioscopic visualization of the area of interest, and successful applications of of all sampling maneuvers with visible tissue seen macroscopically when obtaining mini forceps and standard forceps biopsy samples.

Total Procedure Time120 minutes

The total time to perform ERCP

Total Cholangioscopy Time60 minutes

This is the total time it takes for the dye to be performed during the ERCP.

Adverse Events24 hours

Adverse events were prospectively evaluated at the end of the procedure, at discharge from the endoscopy unit, and by telephone call 24 hours post procedure. Adverse events were defined and graded using the 2010 American Society for Gastrointestinal Endoscopy consensus criteria.

Sampling Times for Each Device15 minutes

The sampling time of the Spybite Biopsy forceps was compared to both the cytology brush and the RJ3 biopsy forceps of any stricture or biliary lesions found on Endoscopic Retrograde Cholangiopancreatography (ERCP).

Cholangioscopy Visualization Time30 minutes

The portion of the total ERCP time spent on Cholangioscopy visualization.

Trial Locations

Locations (1)

Shands at UF Ensopcopy

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath